SOTAC PHARMACEUTICALS
Back to Income Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹104 Cr | ₹77 Cr | ₹73 Cr | ₹49 Cr | ₹29 Cr |
What is the latest Revenue of SOTAC PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹104 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹49 Cr |
| Mar2021 | ₹29 Cr |
How is Revenue of SOTAC PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹104 Cr | 34.00 | |
| Mar2024 | ₹77 Cr | 5.92 | |
| Mar2023 | ₹73 Cr | 49.77 | |
| Mar2022 | ₹49 Cr | 70.76 | |
| Mar2021 | ₹29 Cr | - | |
Compare Revenue of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹123.3 Cr | -9.2% | -12.8% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -9.2% |
-12.8% |
-10% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses